Cover Image

Toward the right treatment at the right time: Modeling the trajectory of cognitive decline to identify the earliest age of change in people with Alzheimer's disease

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	R. Asaad Baksh, André Strydom, Ben Carter, Isabelle Carriere, Karen Ritchie
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Amyloid accumulation, brain atrophy, and cognitive decline in emergent Alzheimer's disease
by: Ying Xia, et al.
Published: (2025)

Cardiometabolic disease, cognitive decline, and brain structure in middle and older age
by: Abigail Dove, et al.
Published: (2024)

Association of latent factors of neuroinflammation with Alzheimer's disease pathology and longitudinal cognitive decline
by: Stefan J. Teipel, et al.
Published: (2024)

Alzheimer's disease neuropathology and longitudinal change in subjective cognitive complaints
by: Alisa Bannerjee, et al.
Published: (2025)

Longitudinal changes in the brain‐age gap in mild cognitive impairment and their relationships with neuropsychological functions and Alzheimer's disease biomarkers
by: Rachel R. Jin, et al.
Published: (2025)

Amyloid‐related changes in fluency in patients with subjective cognitive decline
by: Rosanne L. van den Berg, et al.
Published: (2025)

Validation of regression‐based change formulae for mild cognitive impairment and Alzheimer's disease
by: Kevin Duff, et al.
Published: (2024)

Divergent effects of age on imaging‐based ATN biomarkers and cognition in Alzheimer's disease
by: Lars Frings, et al.
Published: (2025)

Association of arterial structure and function with incident cardiovascular diseases and cognitive decline
by: Caroline Robert, et al.
Published: (2025)

Interchangeability of CSF and PET to identify Alzheimer's disease pathology
by: Samantha C. Burnham, et al.
Published: (2026)

Effects of obesity on plasma biomarker and amyloid PET trajectories in Alzheimer's disease
by: Soheil Mohammadi, et al.
Published: (2025)

Personal social network strengthens adherence to lifestyle changes in individuals with subjective cognitive decline
by: Ismael L. Calandri, et al.
Published: (2024)

Association of a pace of aging epigenetic clock with rate of cognitive decline in the Framingham Heart Study Offspring Cohort
by: Micah J. Savin, et al.
Published: (2024)

The relative contribution of modifiable and non‐modifiable factors for determining cognition in mid‐life individuals at risk for late‐life Alzheimer's disease
by: Bolin Cao, et al.
Published: (2026)

Tracking clinical and neuroimaging progression of Alzheimer's disease by longitudinal trajectories of plasma biomarkers
by: Frederikke Kragh Clemmensen, et al.
Published: (2026)

Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
by: Sofia Toniolo, et al.
Published: (2024)

A systematic review and meta‐analysis of basal microbiota and cognitive function in Alzheimer's disease: A potential target for treatment or a contributor to disease progression?
by: Ana Maria Jimenez‐García, et al.
Published: (2024)

Excessive sleep is associated with worse cognition, cognitive decline, and dementia in mild cognitive impairment
by: Marieclaire Overton, et al.
Published: (2025)

Gender differences in cognitive reserve: An impact on progression in subjective cognitive decline?
by: Giulia Giacomucci, et al.
Published: (2025)

Diagnosing Alzheimer's disease: Which dementia screening test to use in elderly Puerto Ricans with mild cognitive impairment and early Alzheimer's disease?
by: María A. Rodríguez‐Santiago, et al.
Published: (2024)

Identifying cognitive test scores associated with early tau burden in Alzheimer's disease
by: Caitlin M. Terao, et al.
Published: (2025)

Longitudinal changes in functional capacity in frontotemporal dementia and Alzheimer's disease
by: David Foxe, et al.
Published: (2024)

Fixel‐based analysis and free‐water metrics in subjective cognitive decline and cognitive impairment no dementia
by: Zheng Long Lee, et al.
Published: (2026)

Sensory changes in preclinical, prodromal, and clinical Alzheimer's disease and related dementias
by: Willa D. Brenowitz, et al.
Published: (2026)

Midlife sensory and motor functions improve long‐term predictions of cognitive decline and incidence of cognitive impairment
by: Carla R. Schubert, et al.
Published: (2024)

Lower odor identification in subjective cognitive decline: a meta‐analysis
by: Benoît Jobin, et al.
Published: (2025)

Perceptions of cognitive decline among American Indian and Alaska Native elders
by: Cole Allick
Published: (2024)

Biomarkers of chronic inflammation and cognitive decline: A prospective observational study
by: Bhavna A. Guduguntla, et al.
Published: (2024)

Associations of plasma phosphorylated tau217 with cognitive impairment and brain microstructural alterations in Alzheimer's disease
by: Miguel Ángel Rivas‐Fernández, et al.
Published: (2026)

Alzheimer's disease cerebrospinal fluid biomarkers and kidney function in normal and cognitively impaired older adults
by: Ihab Hajjar, et al.
Published: (2024)

Utilizing deep learning to predict Alzheimer's disease and mild cognitive impairment with optical coherence tomography
by: Jacqueline Chua, et al.
Published: (2025)

Brain‐derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementia
by: Cassandra Marotta, et al.
Published: (2025)

Allostatic load dynamics, Alzheimer's disease biomarkers, and progression in individuals with mild cognitive impairment: findings from the Alzheimer's Disease Neuroimaging Initiative
by: Juliana N. Souza‐Talarico, et al.
Published: (2025)

Circulating sphingolipids in relation to cognitive decline and incident dementia: The Cardiovascular Health Study
by: Kristine F. Moseholm, et al.
Published: (2024)

Corrections to “An explainable machine learning model of cognitive decline derived from speech”
Published: (2024)

Sex variation in the relationship between APOE ε4, cognitive decline, and dementia
by: Eleanor M. Kerr, et al.
Published: (2025)

Rest‐activity rhythm characteristics associated with lower cognitive performance and Alzheimer's disease biomarkers in midlife women
by: Alexandra Paget‐Blanc, et al.
Published: (2025)

Retinal vascular biomarkers in mild cognitive impairment and Alzheimer's disease: a comprehensive review and meta‐analysis
by: Sunu Mathew, et al.
Published: (2025)

Resistance and resilience to tau pathology in Alzheimer's disease: Effects of age, sex, and APOE alleles
by: Yury Loika, et al.
Published: (2024)

A systematic review and meta‐analysis of dual‐task outcomes in subjective cognitive decline
by: Talia Salzman, et al.
Published: (2025)